THE COMPANY

Concurrently with the developments in nanotechnology, by creating major conceptual changes in medical methods adopted so far and offering different diagnosis and treatment alternatives, “Nanomedicine”, as a new emerging scientific field, became one of the most studied subjects in the world.

Nanobiomed® is a company that conducts studies on life sciences and advanced technologies related Nanomedicine. The Company was founded in 2008 in order to develop methods or processes for human health based nanotechnology and has the potential to commercialize products.

The company’s scientific & industrial activities divided in 4 different areas of application; namely *Nano-Biotechnology, *Food Test-Analysis, *Biocidal Applications and *Industrial Test Analysis. These activities include both R&D studies on “targeted drug delivery systems, medical diagnosis - follow up - screening systems, nanosensors, regenerative nanomedicine, development of PCR diagnostic kits, application of biocidal active substance” and producing new products as well as delivering consulting and training services.

Dr. Gürer Budak and Dr. Mehmet Budak are scientific founder of Nanobiomed®Inc. They focused on developing and commercializing novel products for targeting delivery systems, nanodiagnostics and regenarative medicine.

Concurrently with the developments in nanotechnology, by creating major conceptual changes in medical methods adopted so far and offering different diagnosis and treatment alternatives, “Nanomedicine”, as a new emerging scientific field, became one of the most studied subjects in the world.

Nanobiomed® is a company that conducts studies on life sciences and advanced technologies related Nanomedicine. The Company was founded in 2008 in order to develop methods or processes for human health based nanotechnology and has the potential to commercialize products.

The company’s scientific & industrial activities divided in 4 different areas of application; namely *Nano-Biotechnology, *Food Test-Analysis, *Biocidal Applications and *Industrial Test Analysis. These activities include both R&D studies on “targeted drug delivery systems, medical diagnosis - follow up - screening systems, nanosensors, regenerative nanomedicine, development of PCR diagnostic kits, application of biocidal active substance” and producing new products as well as delivering consulting and training services.

Dr. Gürer Budak and Dr. Mehmet Budak are scientific founder of Nanobiomed®Inc. They focused on developing and commercializing novel products for targeting delivery systems, nanodiagnostics and regenarative medicine.

MANAGEMENT

Dr. Gürer G. BUDAK (MD, PhD, EMBA)

(Assoc. Prof.)

Founder

President of the Executive Board

Dr. Gürer Güven Budak, the founding Manager of the Nanobiomed®Inc, is a physician and a PhD in Clinical Physiology with an “Executive MBA'.

He is a member of prominent international scientific agencies such as European Technology Platform on NanoMedicine (ETP-NM), European Foundation for Clinical Nanomedicine (CLINAM), NATO Research and Technology Organization (NATO-RTO/HFM 177),and European Union NMP (Nanoscience, Nanotechnologies, Materials & New Production Technologies) Committee.

He is also the founding President of International Society for Nanomedical Science (ISNS)

Dr. Mehmet BUDAK (MD, MS)

Surgical and Clinical Pathologist

Urologist – Surgeon

Scientific Director in Nanobiomed Inc.

Dr. Mehmet Budak, is specialized in Urology and then completed his Clinical and Surgical Pathology training in New York. He participated in many basic and clinical scientific projects in notable universities including Georgetown University, Beth Israel- Albert Einstein College of Medicine, New York University-Lenox Hill Hospital.

He has been continuening his career within Nanobiomed Inc for developing the innovative technologies in diagnostics and theragnostics as inventor and innovator.

Belgin BERKER

Member of the Executive Board

Finance & Industrial Relationship

Belgin Berker is graduated from Hacettepe University - Department of Business Administration. She was Chief Financial Officer at Sadri Şener A.Ş.

She worked at Sera Group Inc. as Director and Board Member between 1995-2014. She is still Vice Chairman and Board Member of the Sera Group Inc.

FACILITY

- Microcentrifuges
- UV lamp
- Heated dry block
- Thermal cycler
- Microwave oven
- Precision Balances
- Electrophoresis power supply
- Mini horizontal electrophoresis system
- Image acquisition and analysis system

- UV transilluminator
- PC Cabinets
- Q-PCR instrument
- Mini centrifuge
- Vortex
- Adjustable micropipette set
- Heated magnetic stirrer
- Laboratory refrigerator
- Refrigerated Microcentrifuge

- Autoclave
- PH Meter
- Homogenizer
- Primary probe software and kits
- Binocular microscopes
- Luminometer
- Various consumables

> - Microcentrifuges
- UV lamp
- Heated dry block
- Thermal cycler
- Microwave oven
- Precision Balances
- Electrophoresis power supply
- Mini horizontal electrophoresis system
- Image acquisition and analysis system

> - UV transilluminator
- PC Cabinets
- Q-PCR instrument
- Mini centrifuge
- Vortex
- Adjustable micropipette set
- Heated magnetic stirrer
- Laboratory refrigerator
- Refrigerated Microcentrifuge

> - Autoclave
- PH Meter
- Homogenizer
- Primary probe software and kits
- Binocular microscopes
- Luminometer
- Various consumables

CONSULTANCY

Tom CULLIGAN

Media & Brand Management

(tom@culliganpartners.com)

Sibel ERTEKİN

Law & Contract Consultancy

(info@sertekinlaw.com)

Randy GRAF

USA Contact Person

(randygraf8888@gmail.com)